Cardiology News, Research Articles | Heart Disease, Disorder Studies


DEA Proposes Less Opioid Production, More Marijuana Research in 2020

The Drug Enforcement Administration (DEA) is proposing a reduction in the amount of Schedule II controlled substances that can be manufactured in the US next year. According to the Notice of Proposed Rulemaking, the DEA proposes the following cuts in opioid production: 31% reduction of fentanyl 19% reduction of hydrocodone 25% reduction of hydromorphone 9%…

Next post in Pediatric Cardiology